{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:28:59Z","timestamp":1794266939288,"version":"4.9.0"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Hypertension, commonly known as high blood pressure, is a widespread health condition affecting a large number of individuals across the globe. Although lifestyle choices and environmental factors are known to have a significant impact on its development, there is growing recognition of the influence of genetic factors in the pathogenesis of hypertension. This review specifically focuses on the hereditary causes of hypertension that are associated with increased sodium transport through the thiazide-sensitive NaCl cotransporter (NCC) or amiloride-sensitive epithelial sodium channel (ENaC), crucial mechanisms involved in regulating blood pressure in the kidneys. By examining genetic mutations and signaling molecules linked to the dysregulation of sodium transport, this review aims to deepen our understanding of the hereditary causes of hypertension and shed light on potential therapeutic targets.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Liddle syndrome (LS) is a genetic disorder that typically manifests early in life and is characterized by hypertension, hypokalemic metabolic alkalosis, hyporeninemia, and suppressed aldosterone secretion. This condition is primarily caused by gain-of-function mutations in ENaC. In contrast, Pseudohypoaldosteronism type II (PHAII) is marked by hyperkalemia and hypertension, alongside other clinical features such as hyperchloremia, metabolic acidosis, and suppressed plasma renin levels. PHAII results from overactivations of NCC, brought about by gain-of-function mutations in its upstream signaling molecules, including WNK1 (with no lysine (K) 1), WNK4, Kelch-like 3 (KLHL3), and cullin3 (CUL3).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>NCC and ENaC are integral components, and their malfunctions lead to disorders like LS and PHAII, hereditary causes of hypertension. Current treatments for LS involve ENaC blockers (e.g., triamterene and amiloride) in conjunction with low-sodium diets, effectively normalizing blood pressure and potassium levels. In PHAII, thiazide diuretics, which inhibit NCC, are the mainstay treatment, albeit with some limitations and potential side effects. Ongoing research in developing alternative treatments, including small molecules targeting key regulators, holds promise for more effective and tailored hypertension solutions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001304","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T11:46:41Z","timestamp":1698839201000},"page":"211-218","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Hereditary causes of hypertension due to increased sodium transport"],"prefix":"10.1097","volume":"36","author":[{"given":"Jinwei","family":"Zhang","sequence":"first","affiliation":[{"name":"Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian"},{"name":"State Key Laboratory of Chemical Biology, Research Center of Chemical Kinomics, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China"},{"name":"Institute of Biomedical and Clinical Sciences, Medical School, Faculty of Health and Life Sciences, University of Exeter, Hatherly Laboratories, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,1]]},"reference":[{"key":"R3-20250730","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls","volume":"447","author":"Wellcome Trust Case Control Consortium","year":"2007","journal-title":"Nature"},{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/ng.3667","article-title":"The genetics of blood pressure regulation and its target organs from association studies in 342 415 individuals","volume":"48","author":"Ehret","year":"2016","journal-title":"Nat Genet"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ng.3715","article-title":"Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation","volume":"49","author":"Hoffmann","year":"2017","journal-title":"Nat Genet"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00431-011-1440-7","article-title":"Monogenic forms of hypertension","volume":"171","author":"Simonetti","year":"2012","journal-title":"Eur J Pediatr"},{"issue":"(Pt 2)","key":"R7-20250730","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1111\/j.1753-4887.2005.tb00152.x","article-title":"Human water needs","volume":"63","author":"Sawka","year":"2005","journal-title":"Nutr Rev"},{"key":"R9-20250730","first-page":"1","article-title":"Gitelman syndrome","author":"Zhang","year":"2023","journal-title":"Genetic syndromes: A comprehensive reference guide"},{"key":"R10-20250730","doi-asserted-by":"crossref","first-page":"F1021","DOI":"10.1152\/ajprenal.0085.2001","article-title":"Distribution of transcellular calcium and sodium transport pathways along mouse distal nephron","volume":"281","author":"Loffing","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"R11-20250730","first-page":"F367","article-title":"Developmental expression of sodium entry pathways in rat nephron","volume":"276","author":"Schmitt","year":"1999","journal-title":"Am J Physiol"},{"issue":"(Pt 2)","key":"R12-20250730","first-page":"F900","article-title":"Expression of the thiazide-sensitive Na-Cl cotransporter in rat and human kidney","volume":"269","author":"Obermuller","year":"1995","journal-title":"Am J Physiol"},{"key":"R13-20250730","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1152\/physrev.00044.2018","article-title":"Regulation of the renal NaCl cotransporter and Its role in potassium homeostasis","volume":"100","author":"Hoorn","year":"2020","journal-title":"Physiol Rev"},{"key":"R14-20250730","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1038\/s41598-017-03510-5","article-title":"Aldosterone modulates the association between NCC and ENaC","volume":"7","author":"Wynne","year":"2017","journal-title":"Sci Rep"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.gene.2015.12.061","article-title":"Epithelial sodium channel (ENaC) family: phylogeny, structure-function, tissue distribution, and associated inherited diseases","volume":"579","author":"Hanukoglu","year":"2016","journal-title":"Gene"},{"key":"R16-20250730","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.39340","article-title":"Structure of the human epithelial sodium channel by cryo-electron microscopy","volume":"7","author":"Noreng","year":"2018","journal-title":"Elife"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"F328","DOI":"10.1152\/ajprenal.00116.2012","article-title":"The epithelial sodium channel delta-subunit: new notes for an old song","volume":"303","author":"Giraldez","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"R18-20250730","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1161\/HYPERTENSIONAHA.122.18924","article-title":"Epithelial sodium channel delta subunit Is expressed in human arteries and has potential association with hypertension","volume":"79","author":"Paudel","year":"2022","journal-title":"Hypertension"},{"key":"R19-20250730","first-page":"199","article-title":"A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion","volume":"76","author":"Liddle","year":"1963","journal-title":"Trans Assoc Am Physicians"},{"key":"R20-20250730","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cca.2014.05.015","article-title":"Molecular genetics of Liddle's syndrome","volume":"436","author":"Yang","year":"2014","journal-title":"Clin Chim Acta"},{"key":"R21-20250730","doi-asserted-by":"crossref","first-page":"F377","DOI":"10.1152\/ajprenal.00143.2002","article-title":"Concerted action of ENaC, Nedd4-2, and Sgk1 in transepithelial Na(+) transport","volume":"283","author":"Kamynina","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/ajh\/hpaa037","article-title":"Pediatric Liddle syndrome caused by a novel SCNN1G variant in a Chinese family and characterized by early-onset hypertension","volume":"33","author":"Fan","year":"2020","journal-title":"Am J Hypertens"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1681\/ASN.2016111163","article-title":"A missense mutation in the extracellular domain of \u03b1ENaC causes Liddle syndrome","volume":"28","author":"Salih","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2215\/CJN.05760513","article-title":"Collecting duct principal cell transport processes and their regulation","volume":"10","author":"Pearce","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R25-20250730","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/emboj\/16.5.899","article-title":"A mutation causing pseudohypoaldosteronism type 1 identifies a conserved glycine that is involved in the gating of the epithelial sodium channel","volume":"16","author":"Grunder","year":"1997","journal-title":"EMBO J"},{"key":"R26-20250730","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00332.2022","article-title":"A mild and transient form of autosomal recessive pseudohypoaldosteronism type 1 caused by a novel mutation in the SCNN1A gene","volume":"325","author":"Efthymiadou","year":"2023","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/jch.12598","article-title":"Prevalence of Liddle syndrome among young hypertension patients of undetermined cause in a Chinese population","volume":"17","author":"Wang","year":"2015","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/HJH.0000000000001556","article-title":"Analysis of the genes involved in Mendelian forms of low-renin hypertension in Chinese early-onset hypertensive patients","volume":"36","author":"Liu","year":"2018","journal-title":"J Hypertens"},{"key":"R29-20250730","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/HYPERTENSIONAHA.117.10491","article-title":"Three reportedly unrelated families with Liddle Syndrome inherited from a common ancestor","volume":"71","author":"Pagani","year":"2018","journal-title":"Hypertension"},{"key":"R30-20250730","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ng0196-24","article-title":"Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter","volume":"12","author":"Simon","year":"1996","journal-title":"Nat Genet"},{"key":"R31-20250730","first-page":"1019","article-title":"Novel molecular variants of the Na-Cl cotransporter gene are responsible for Gitelman syndrome","volume":"59","author":"Mastroianni","year":"1996","journal-title":"Am J Hum Genet"},{"key":"R32-20250730","doi-asserted-by":"crossref","first-page":"F204","DOI":"10.1152\/ajprenal.00429.2015","article-title":"Alternative splice variant of the thiazide-sensitive NaCl cotransporter: a novel player in renal salt handling","volume":"310","author":"Tutakhel","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"R33-20250730","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2023.09.002","article-title":"The role of SLC12A family of cationchloride cotransporters and drug discovery methodologies","author":"Zhang","year":"2023","journal-title":"J Pharm Anal"},{"key":"R34-20250730","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1073\/pnas.90.7.2749","article-title":"Primary structure and functional expression of a cDNA encoding the thiazide-sensitive, electroneutral sodium-chloride cotransporter","volume":"90","author":"Gamba","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"R35-20250730","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/01.ASN.0000043903.93452.D0","article-title":"N-glycosylation at two sites critically alters thiazide binding and activity of the rat thiazide-sensitive Na+","volume":"14","author":"Hoover","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R36-20250730","doi-asserted-by":"crossref","first-page":"24302","DOI":"10.1074\/jbc.M303101200","article-title":"The structural unit of the thiazide-sensitive NaCl cotransporter is a homodimer","volume":"278","author":"de Jong","year":"2003","journal-title":"J Biol Chem"},{"key":"R37-20250730","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1046\/j.1523-1755.2001.059002710.x","article-title":"Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life","volume":"59","author":"Cruz","year":"2001","journal-title":"Kidney Int"},{"key":"R38-20250730","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1445-5994.1986.tb01145.x","article-title":"The syndrome of hypertension and hyperkalemia with normal glomerular filtration rate: Gordon's syndrome","volume":"16","author":"Gordon","year":"1986","journal-title":"Aust N Z J Med"},{"key":"R39-20250730","article-title":"Pseudohypoaldosteronism type II","author":"Ellison","year":"1993"},{"key":"R40-20250730","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature10814","article-title":"Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities","volume":"482","author":"Boyden","year":"2012","journal-title":"Nature"},{"key":"R41-20250730","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1161\/CIRCULATIONAHA.105.555474","article-title":"Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population","volume":"112","author":"Tobin","year":"2005","journal-title":"Circulation"},{"key":"R42-20250730","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/imj.1970.19.4.287","article-title":"Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction","volume":"19","author":"Gordon","year":"1970","journal-title":"Australas Ann Med"},{"key":"R43-20250730","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1046\/j.1440-1681.2001.03575.x","article-title":"Phenotypic and genetic heterogeneity of familial hyperkalaemic hypertension (Gordon syndrome)","volume":"28","author":"Achard","year":"2001","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R44-20250730","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1210\/jcem.87.7.8449","article-title":"Pseudohypoaldosteronism type II: marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density","volume":"87","author":"Mayan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R45-20250730","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0002-9343(03)00054-8","article-title":"Familial hyperkalemic hypertension: phenotypic analysis in a large family with the WNK1 deletion mutation","volume":"114","author":"Achard","year":"2003","journal-title":"Am J Med"},{"key":"R46-20250730","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1681\/ASN.2005030314","article-title":"Familial hyperkalemic hypertension","volume":"17","author":"Hadchouel","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R47-20250730","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng0697-202","article-title":"Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21","volume":"16","author":"Mansfield","year":"1997","journal-title":"Nat Genet"},{"key":"R48-20250730","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/303020","article-title":"A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension","volume":"67","author":"Disse-Nicodeme","year":"2000","journal-title":"Am J Hum Genet"},{"key":"R49-20250730","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/boc.201300069","article-title":"Regulation of with-no-lysine kinase signaling by Kelch-like proteins","volume":"106","author":"Uchida","year":"2014","journal-title":"Biol Cell"},{"key":"R50-20250730","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/ng.2218","article-title":"KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal nephron","volume":"44","author":"Louis-Dit-Picard","year":"2012","journal-title":"Nat Genet"},{"key":"R51-20250730","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1042\/CS20130326","article-title":"Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon's syndrome)","volume":"126","author":"Glover","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"R52-20250730","doi-asserted-by":"crossref","first-page":"29150","DOI":"10.1074\/jbc.273.44.29150","article-title":"Phenotype resembling Gitelman's syndrome in mice lacking the apical Na+-Cl- cotransporter of the distal convoluted tubule","volume":"273","author":"Schultheis","year":"1998","journal-title":"J Biol Chem"},{"key":"R53-20250730","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"R54-20250730","doi-asserted-by":"crossref","first-page":"C150","DOI":"10.1152\/ajpcell.00418.2019","article-title":"Regulating ENaC's gate","volume":"318","author":"Kleyman","year":"2020","journal-title":"Am J Physiol Cell Physiol"},{"key":"R55-20250730","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1159\/000507580","article-title":"Premature stroke secondary to severe hypertension results from Liddle syndrome caused by a novel SCNN1B mutation","volume":"45","author":"Fan","year":"2020","journal-title":"Kidney Blood Press Res"},{"key":"R56-20250730","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1124\/mol.64.4.848","article-title":"Mutations in the epithelial Na+ channel ENaC outer pore disrupt amiloride block by increasing its dissociation rate","volume":"64","author":"Kellenberger","year":"2003","journal-title":"Mol Pharmacol"},{"key":"R57-20250730","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/B978-0-12-801238-3.65187-5","article-title":"Liddle syndrome","author":"Rossi","year":"2019","journal-title":"Encyclopedia of endocrine diseases, 2nd edn"},{"key":"R58-20250730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/156250","article-title":"A therapeutic challenge: Liddle's syndrome managed with amiloride during pregnancy","volume":"2014","author":"Caretto","year":"2014","journal-title":"Case Rep Obstetr Gynecol"},{"key":"R59-20250730","doi-asserted-by":"crossref","first-page":"F1113","DOI":"10.1152\/ajprenal.00609.2019","article-title":"Ubiquitination of renal ENaC subunits in vivo","volume":"318","author":"Frindt","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"R60-20250730","doi-asserted-by":"crossref","first-page":"F30","DOI":"10.1152\/ajprenal.00455.2018","article-title":"MST3 is involved in ENaC-mediated hypertension","volume":"317","author":"Lu","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"R61-20250730","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1586\/erc.10.27","article-title":"Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics","volume":"8","author":"Duarte","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R62-20250730","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s41586-023-05718-0","article-title":"Structure and thiazide inhibition mechanism of the human Na-Cl cotransporter","volume":"614","author":"Fan","year":"2023","journal-title":"Nature"},{"issue":"(Pt 2)","key":"R63-20250730","first-page":"F137","article-title":"Adaptation of distal convoluted tubule of rats. II. Effects of chronic thiazide infusion","volume":"261","author":"Morsing","year":"1991","journal-title":"Am J Physiol"},{"key":"R64-20250730","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1524-6175.2004.03789.x","article-title":"Diuretic-related side effects: development and treatment","volume":"6","author":"Sica","year":"2004","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R65-20250730","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1093\/hmg\/ddv185","article-title":"Critical role of the SPAK protein kinase CCT domain in controlling blood pressure","volume":"24","author":"Zhang","year":"2015","journal-title":"Hum Mol Genet"},{"key":"R66-20250730","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nchembio.2168","article-title":"Small-molecule WNK inhibition regulates cardiovascular and renal function","volume":"12","author":"Yamada","year":"2016","journal-title":"Nat Chem Biol"},{"key":"R67-20250730","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.apsb.2020.09.009","article-title":"Regulatory control of the Na+-Cl- co-transporter NCC and its therapeutic potential for hypertension","volume":"11","author":"Meor Azlan","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"R68-20250730","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41401-020-0474-7","article-title":"WNK-SPAK\/OSR1-NCC kinase signaling pathway as a novel target for the treatment of salt-sensitive hypertension","volume":"42","author":"Brown","year":"2021","journal-title":"Acta Pharmacol Sin"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:02:37Z","timestamp":1753898557000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001304","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,1]]}}}